{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/crohns-disease/background-information/prognosis/","result":{"pageContext":{"chapter":{"id":"d2c1974d-3136-58a1-b5ba-55826ab8a286","slug":"prognosis","fullItemName":"Prognosis","depth":2,"htmlHeader":"<!-- begin field d9dc02cd-5331-4da3-ae72-e2b75410f614 --><h2>What is the prognosis?</h2><!-- end field d9dc02cd-5331-4da3-ae72-e2b75410f614 -->","summary":"","htmlStringContent":"<!-- begin item 252c968d-1426-41e7-a5fe-5663a85e8f5a --><!-- begin field da716bd8-7b2e-44f8-ad9a-7e4c31fbcf89 --><ul><li><strong>Crohn's disease is a lifelong condition, typified by periods of relapse and remission with recurrent cycles of inflammation</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Kalla, 2014</a>]<strong>.</strong><ul><li>A review of population-based studies of the natural history of Crohn's disease in adults found [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Peyrin-Biroulet et al, 2010</a>]:<ul><li>The location of the disease (ileitis, colitis, or ileo-colitis) tended to remain stable over time.</li><li>About 30% of people had an intestinal stricture or fistula at diagnosis.</li><li>About 10% of people had prolonged clinical remission.</li><li>Each year, about 20% of people were admitted to hospital.</li><li>About 50% of people underwent surgery within 10<strong> </strong>years of diagnosis.</li><li>About 50% of people undergoing surgery had a recurrence of symptoms within 10<strong> </strong>years of diagnosis.</li></ul></li><li>A European evidence-based consensus paper cites cohort studies that show at least 1 in 3 people with Crohn's disease have a mild to moderate course in the long-term, with little or no requirement for corticosteroid drug treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Gomollon, 2017</a>].</li></ul></li><li><strong>The all-cause mortality rate is higher than in the general population (standardized mortality ratio of 1.38 in cohort studies) </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Bewtra, 2013</a>]<strong>. </strong>The increased risk of mortality is greatest in the two years after diagnosis, and in those with upper gastrointestinal disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Mowat et al, 2011</a>].</li><li><strong>Factors which may suggest a poor prognosis include </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/crohns-disease/references/\">Ruemmele, 2014</a>]<strong>:</strong><ul><li>Early age of onset.</li><li>Perianal disease.</li><li>Corticosteroid use at presentation.</li><li>Severe symptoms at presentation.</li><li>A history of more than one surgical resection.</li><li>A history of complicated disease, such as abscess, fistulizing or penetrating disease.</li></ul></li></ul><!-- end field da716bd8-7b2e-44f8-ad9a-7e4c31fbcf89 --><!-- end item 252c968d-1426-41e7-a5fe-5663a85e8f5a -->","topic":{"id":"a55bf0e9-c7ea-505e-b7ff-5093105336e5","topicId":"7057d96d-a527-4391-84a1-c39953de3eae","topicName":"Crohn's disease","slug":"crohns-disease","lastRevised":"Last revised in August 2020","chapters":[{"id":"9c1b7d20-f572-5a3c-845f-3f4b65f646e1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6b9f2bb0-4b7b-5373-ace6-15e38cc8904f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2a50fc53-dced-5bb1-83cf-20d5ce4f9e8e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"a5629107-6649-5a0c-a706-90ad8bf14aa7","slug":"changes","fullItemName":"Changes"},{"id":"1a920dcd-3a15-527f-9fc2-97be951c56cc","slug":"update","fullItemName":"Update"}]},{"id":"79cdca68-ce3a-5435-bca1-8393c4d809a6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"123f065a-c1e6-59ef-a0f6-fa3212214c90","slug":"goals","fullItemName":"Goals"},{"id":"d3e5c61e-a5b9-586a-8698-69a0c0f79a5f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b41011e0-33e6-52d3-9434-5f29d0baeeb8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f3bcc082-58a6-51db-a805-173080268884","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a5948dc8-4eac-58f3-8d64-68a80aeb4059","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7082be71-4889-5e95-bd5f-27917f361203","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"65c06b36-b686-57f1-be7f-6fae62c4deb0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3fa00303-9d62-51cf-819b-dbad0041831e","slug":"definition","fullItemName":"Definition"},{"id":"6890604a-a1f2-5be2-94b0-d2471c85fdbc","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"0d0050de-d075-540a-9c7c-ed50c6ed1243","slug":"prevalence","fullItemName":"Prevalence"},{"id":"05aa7fe4-c9b9-51f0-bf41-2369861eba6c","slug":"complications","fullItemName":"Complications"},{"id":"67cb018a-e79e-5636-bd84-67fe57bf28c2","slug":"extra-intestinal-manifestations","fullItemName":"Extra-intestinal manifestations"},{"id":"d2c1974d-3136-58a1-b5ba-55826ab8a286","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"14a7e92b-d43e-5b64-b357-c1a4d063afb3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"32cf487b-92a9-5d33-949e-023023aede46","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5440444f-1635-5240-bea3-54d84e6067f5","slug":"investigations","fullItemName":"Investigations"},{"id":"f7a2e718-21ad-5956-a862-8f8406ca2f8b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a49169c9-856e-51c3-94cc-76e3f02f6073","fullItemName":"Management","slug":"management","subChapters":[{"id":"c4ee1de2-52a2-5289-82bd-c3377ae84b6c","slug":"suspected-crohns-disease","fullItemName":"Scenario: Suspected Crohn's disease"},{"id":"b3e71531-764c-58b2-aa02-ece1993fb53f","slug":"confirmed-crohns-disease","fullItemName":"Scenario: Confirmed Crohn's disease"},{"id":"b822e9cd-227b-54db-9bfd-57cf52a4e663","slug":"fertility-pregnancy-breastfeeding-with-crohns-disease","fullItemName":"Scenario: Fertility, pregnancy, and breastfeeding with Crohn's disease"},{"id":"9a2be3f2-65c0-5e62-9b89-9aef0f5df386","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"82ab51ab-f7f0-5464-a0dc-cb566bb3f629","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"771b1e3f-3c10-5c86-bbb4-5ff669ca2d44","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fb296c54-fd91-56fc-ab19-6fd4bb759030","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"efff8f5f-5a26-5e56-a428-b3155279fcef","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"420029a0-c51b-5ffc-a7f3-71940eccb5ba","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"09872916-a68f-57e9-b064-aab1b782ca32","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"dc3e796d-dda1-58f4-b43f-f4ce100ebfc2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a0922fda-b50c-5cff-8ccd-19fef4fe47f1","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"65c06b36-b686-57f1-be7f-6fae62c4deb0","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}